Piramal Pharma Limited (BOM:543635)
India · Delayed Price · Currency is INR 177.10
+5.20 (3.03%)
At close: Jul 10, 2026
Piramal Pharma Market Cap
Piramal Pharma has a market cap or net worth of 230.44 billion as of July 13, 2026. Its market cap has decreased by -9.72% in one year.
Market Cap
230.44B
Enterprise Value
274.00B
Revenue
88.69B
Ranking
n/a
PE Ratio
n/a
Stock Price
177.10
Market Cap Chart
Since October 19, 2022, Piramal Pharma's market cap has increased from 226.73B to 230.44B, an increase of 1.63%. That is a compound annual growth rate of 0.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 235.12B | 2.82% |
| Dec 31, 2025 | 228.67B | -35.22% |
| Dec 31, 2024 | 352.98B | 92.16% |
| Dec 29, 2023 | 183.69B | 34.26% |
| Dec 30, 2022 | 136.81B | -39.66% |
| Oct 19, 2022 | 226.73B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Abbott India | 576.39B |
| GlaxoSmithKline Pharmaceuticals | 412.59B |
| J. B. Chemicals & Pharmaceuticals | 391.39B |
| Rubicon Research | 235.82B |
| Granules India | 220.43B |
| AstraZeneca Pharma India | 203.10B |
| Caplin Point Laboratories | 196.52B |
| Jubilant Pharmova | 152.20B |